The Relationship Between Sickle Cell Disease and Sudden Onset Sensorineural Deafness.

deafness hemoglobin sickle cell scd sensorineural hearing loss sickle cell anemia sickle cell disease

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
27 Jul 2020
Historique:
entrez: 1 9 2020
pubmed: 31 8 2020
medline: 31 8 2020
Statut: epublish

Résumé

Sickle cell anemia (SCA) is a hereditary hemoglobin (Hb) disorder associated with a very specific molecular lesion, which is the exchange of glutamic acid for valine in the sixth residue of the Hb beta chain, originating the S Hb. It is characterized by intermittent episodes of vascular occlusion and end-organ damage. Progressive organ damage may affect any organ with brain, eyes, pulmonary, hepatobiliary, spleen, genitourinary, and the musculoskeletal systems being the most commonly involved and reported. Other complications of the disease that have not been well described or studied include cranio-orbital syndromes, oropharyngeal syndromes, periodontal disease, and otologic syndromes. Considering the vaso-occlusive nature of sickle cell disease (SCD), the potential for auditory damage is not unexpected. However, the incidence of subjective hearing impairment among SCA is very low and and little is known about the relationship between SCA and hearing loss. Here we report a 43-year-old female with SCA who presented with sudden bilateral hearing loss and generalized body ache and admitted as a case of sensorineural deafness with vascular crisis; she received IV fluid and analgesia and improved after five days from the therapy.

Identifiants

pubmed: 32864242
doi: 10.7759/cureus.9413
pmc: PMC7449647
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e9413

Informations de copyright

Copyright © 2020, Abdelmahmuod et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Neuropsychol Rev. 2001 Dec;11(4):179-96
pubmed: 11883668
J Commun Disord. 2005 Jul-Aug;38(4):321-9
pubmed: 15862814
Bull Soc Pathol Exot. 2002 Nov;95(4):248-9
pubmed: 12596370
Indian J Endocrinol Metab. 2013 Nov;17(6):962-8
pubmed: 24381868
Hematology. 2018 Dec;23(10):849-855
pubmed: 29806800
Postgrad Med J. 1987 Sep;63(743):751-3
pubmed: 3444798
Acta Otolaryngol Suppl. 1994;514:85-8
pubmed: 8073894

Auteurs

Elabbass Abdelmahmuod (E)

Internal Medicine, Hamad Medical Corporation, Doha, QAT.

Mohamed A Yassin (MA)

Hematology and Oncology, Hamad General Hospital, Doha, QAT.

Mohanad Ahmed (M)

Internal Medicine, Hamad Medical Corporation, Doha, QAT.

Elrazi Ali (E)

Internal Medicine, Hamad Medical Corporation, Doha, QAT.

Classifications MeSH